Lindsay R. Docto
As an associate in Dorsey’s Benefits & Compensation Group, Lindsay advises clients on benefits issues in connection with mergers and acquisitions. Lindsay also counsels clients on ERISA and issues that arise in maintaining retirement and health and welfare plans for companies at various stages of growth. In addition, Lindsay provides guidance to clients working to comply with Affordable Care Act requirements as companies assess the applicability of market reforms and establish 4980H reporting procedures.
With plenty of experience in private practice and as an Assistant General Counsel for Pay & Benefits in a Fortune 50 Company, Bob understands that employee benefits law isn’t for everyone. That’s why he takes pride in listening carefully and responding with clear answers and advice that can be followed by busy clients.
Tim Goodman works with employers on medical plans, retirement plans, executive compensation, and a wide range of benefits. Tim works with a broad array of employers, with a special focus on assisting cooperatives, agribusiness companies, hospitals and health care entities, banks and financial institutions, and Alaskan Native Corporations.Employers have Tim provide advice on health care reform (the ACA), wellness plans, and other welfare plan matters (ranging from cafeteria and health FSAs to severance and tuition plans). With respect to health care reform, Tim advises employers on the new fees (from the employer shared responsibility fee to the Cadillac tax), assists them in preparing for reporting on Form 1095-C, and explains the new requirements ranging from notice requirements to plan mandates.Tim recognizes the complex nature of the rules governing retirement plans and works with employers to review operations, address errors, and help employers maintain the tax-qualified status of their plans. Tim advises employers on qualified and nonqualified retirement plans (including defined benefit, 401(k), 403(b), 457(b), and 457(f) plans, and section 409A).
- Next story Implied Certification, Escobar, and the Impact on Healthcare Providers
- Previous story Failure to Disclose Best Pricing: Pharmaceutical Companies Settle FCA Claims for $784 Million